Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Cancer Metastatic × pembrolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Melanoma 16 Breast Neoplasms 9 Neoplasms 8 Triple Negative Breast Neoplasms 7 Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Carcinoma, Hepatocellular 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Lymphoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Hodgkin Disease 3 Glioblastoma 3 Esophageal Neoplasms 3 Carcinoma 3 Neoplasms, Squamous Cell 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2

Interventions

Oxaliplatin 5 Irinotecan 5 Capecitabine 4 Panitumumab 3 Bevacizumab 3 Leucovorin 2 Fluorouracil 2 Cetuximab 2 spartalizumab 1 regorafenib 1 raltitrexed 1 pembrolizumab 1 camrelizumab 1 aflibercept 1 Radiotherapy 1 Radiosurgery 1 Lycopene 1 Loperamide 1 Ethiodized Oil 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04262687 2023-08-18

POCHI

Federation Francophone de Cancerologie Digestive

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡